lillycorporatehq

Lilly three strikes in three years not out in Teva patent challenge

January 13, 2017
Medical Communications, Sales and Marketing Eli Lilly, Teva, generics, lilly, patent

Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …

NICE recommends Novartis’ previously CDF-exclusive kidney cancer treatment

January 13, 2017
Medical Communications, Sales and Marketing Afinitor, CDF, NICE, Novartis, everolimus

In a reappraisal decision by NICE, everolimus (Novartis’ Afinitor) has been recommended for the treatment of advanced renal cell carcinoma …

wales_flag

Welsh government launches £80 million fund for newly approved drugs

January 13, 2017
Medical Communications Wales, Welsh Government, drug fund

The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …

1280px-epi-pen_1

Drugstore chain CVS offers EpiPen generic for 600% cheaper

January 12, 2017
Medical Communications, Sales and Marketing CVS, Mylan, epipen

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …

IBM and FDA collaborate to protect patient data with blockchain technology

January 12, 2017
Medical Communications, Research and Development FDA, blockchain, blockchain technology, ibm

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …

entrance_takeda_i020_v1

Takeda invests $125m in Maverick T-cell platform partnership

January 12, 2017
Research and Development Maverick, Takeda

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …

biocon_office

Mylan and Biocon apply to FDA for biosimilar approval

January 12, 2017
Sales and Marketing Biocon, FDA, Mylan, biosimilar, trastuzumab

Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …

shire_image_4

Shire fined $350 million in largest-ever bribery case of its kind

January 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

New immunotherapy-based cancer research limits cancer spread by 75%

January 12, 2017
Medical Communications, Research and Development Cancer, cancer research, immunotherapy

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

riodejaneiro_aerea_aeroportogaleao-131756cut

Rio De Janeiro’s primary airport awarded CEIV Pharma certification

January 11, 2017
Manufacturing and Production Rio Galeao, cargo

Rio Galeão, the main airport serving Rio De Janeiro, has been awarded Centre of Excellence for Independent Validators (CEIV) Pharma …

MSD and Lilly announce immuno-oncology collaboration

January 11, 2017
Medical Communications, Research and Development Eli Lilly, Lartruvo, MSD, keytruda, lilly

MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …

MPS extends its range of child resistant packaging

January 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …

merck_and_co

MSD looks to jump the gun with combination immunotherapy application

January 11, 2017
Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …

c_agsandrew_-_fotolia

Philips and Illumina partner up for integrated genomics oncology solution

January 11, 2017
Research and Development Illumina, Philips, oncology

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

joe_biden_and_obama

New formulary ‘bank’ to aid research into combination therapies

January 11, 2017
Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy

As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …

index_ph001

Daiichi pulls out of India with closure of 170-strong R&D plant

January 11, 2017
Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma

Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …

FDA warns that St. Jude’s heart devices could be hacked

January 11, 2017
Medical Communications, Research and Development Abbott, Muddy waters, St. Jude, medsec

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …

Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE)

January 10, 2017
Medical Equipment Supplier, SCOPE2017

Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE) Woodley Equipment Company  is exhibiting at Summit for Clinical …

SHL brings innovation to Pharmapack Europe 2017

January 10, 2017
Manufacturing and Production, Research and Development, Sales and Marketing auto injector, connectivity, delivery devices, smart packaging

As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …

ovarian_cancer

Research finds cancer cells spread even before tumour development

January 10, 2017
Manufacturing and Production, Research and Development Cancer

Studies at the Icahn School of Medicine in New York City and the University of Regensburg in Germany have found …

The Gateway to Local Adoption Series

Latest content